Staphylococcus aureus - NRS77
Other designations ( NCTC 8325; RN1 )
|
|
|
| Demographic Information: |
|
| Country/State: |
United Kingdom |
Date of Isolation: |
01/01/1960 |
| Patient Age: |
N/A |
Gender: |
N/A |
| Patient Location: |
N/A |
Patient Service: |
N/A |
| Culture Source: |
Other (N/A) |
|
| Phenotypic Properties: |
non-pigmented, agr group I
|
|
| Genotypic Properties: |
rsbU-, hib-, agr+, sak+
|
|
|
| Literature Citation: |
Novick, R. "Properties of a cryptic high-frequency transducing phage in Staphylococcus aureus." Virology 1967;33:155-166.
|
|
| Comment: |
Procured from Dr. J. Iandolo.
RN1 was used by Dr. R. Novick as standard strain in laboratory research for typing phage 47.
|
| |
| Description: |
Strain sequenced at Univ. of Oklahoma
|
|
| Repositories: |
Genome Sequenced Strains
Research Strains
|
|
|
|
S = Susceptible; R = Resistant; NS = Not Susceptible; I =Intermediate; N/A = Not Available P= Pending results |
|
|
NARSA Antimicrobial Profile for Other Antimicrobial Agents
|
|
Molecular Characterization Data
|
|
| Ciprofloxacin |
= 0.25 |
S |
| Clindamycin |
= 0.06 |
S |
| Erythromycin |
= 0.25 |
S |
| Gentamicin |
= 1 |
S |
| Linezolid |
= 1 |
S |
| Oxacillin |
= 0.25 |
S |
| Penicillin |
= 0.03 |
S |
| Quinupristin/dalfopristin |
= 0.25 |
S |
| Teicoplanin |
= 0.5 |
S |
| Trimeth/sulfa |
<= 0.25/4.75 |
S |
| Vancomycin |
= 1 |
S |
|
|
|
|
|
|
|
|
